Inventor · disambiguated record
Sanford L. Boye
Also filed as: BOYE SANFORD L · BOYE SANFORD LEON
17 granted patents·13 pending applications·112 citations·filing 2007–2025
93Inventor score
Top patents by PatentIndex Score
30 records- 0195US10308957B2rAAV vectors and methods for transduction of photoreceptors and RPE cellsUNIV FLORIDA·Filed 2015·Granted Jun 4, 2019·13 cites·8 claims
- 0293US11332502B2Modified AAV capsid proteins and uses thereofUNIV FLORIDA·Filed 2020·Granted May 17, 2022·4 cites·20 claims
- 0393US11325956B2Dual-AAV vector-based systems and methods for delivering oversized genes to mammalian cellsUNIV FLORIDA·Filed 2019·Granted May 10, 2022·7 cites·11 claims
- 0492US8298818B2Self-complementary adeno-associated virus having a truncated CMV-chicken β-actin promoterBOYE SANFORD LEON·Filed 2007·Granted Oct 30, 2012·37 cites·11 claims
- 0591US11141425B2Enhancing AAV-mediated transduction of ocular tissues with hyaluronic acidUNIV FLORIDA·Filed 2020·Granted Oct 12, 2021·2 cites·20 claims
- 0691US10793606B2Modified AAV capsid proteins and uses thereofUNIV FLORIDA·Filed 2019·Granted Oct 6, 2020·7 cites·20 claims
- 0790US10648000B2rAAV vector compositions, methods for targeting vascular endothelial cells and use in treatment of type I diabetesUNIV FLORIDA·Filed 2016·Granted May 12, 2020·9 cites·13 claims
- 0890US10214572B2Dual-AAV vector-based systems and methods for delivering oversized genes to mammalian cellsUNIV FLORIDA·Filed 2014·Granted Feb 26, 2019·16 cites·7 claims
- 0989US11744851B2Enhancing AAV-mediated transduction of ocular tissues with hyaluronic acidUNIV FLORIDA·Filed 2021·Granted Sep 5, 2023·1 cites·18 claims
- 1085US9770491B2AAV-mediated gene therapy for RPGR X-linked retinal degenerationUNIV PENNSYLVANIA·Filed 2013·Granted Sep 26, 2017·9 cites·12 claims
- 1180US11806408B2Methods and compositions for treating cone-rod retinal dystrophyUNIV FLORIDA·Filed 2018·Granted Nov 7, 2023·1 cites·15 claims
- 1280US10383922B2AAV-mediated gene therapy for RPGR X-linked retinal degenerationUNIV PENNSYLVANIA·Filed 2017·Granted Aug 20, 2019·3 cites·12 claims
- 1374US11767346B2Modified AAV capsid proteins and uses thereofUNIV FLORIDA·Filed 2022·Granted Sep 26, 2023·0 cites·19 claims
- 1473US2022186260A1Raav-guanylate cyclase compositions and methods for treating leber's congenital amaurosis-1 (lca1)UNIV FLORIDA·Filed 2021·Application pending·0 cites
- 1572US9375491B2Chimeric promoter for cone photoreceptor targeted gene therapyUNIV FLORIDA·Filed 2012·Granted Jun 28, 2016·1 cites·5 claims
- 1669US9816108B2rAAV-guanylate cyclase compositions and methods for treating lebers congenital amaurosis-1 (LCA1)BOYE SHANNON ELIZABETH·Filed 2011·Granted Nov 14, 2017·2 cites·7 claims
- 1768US2025367325A1Compositions and methods for expressing otoferlinUNIV FLORIDA·Filed 2025·Application pending·0 cites
- 1867US2025381298A1Dual aav-myo7a vectors with improved safety for the treatment of ush1bUNIV FLORIDA·Filed 2025·Application pending·0 cites
- 1965US2021130421A1Dual-aav vector-based systems and methods for delivering oversized genes to mammalian cellsUNIV FLORIDA·Filed 2020·Application pending·0 cites
- 2062US2019343920A1Aav-mediated gene therapy for nphp5 lca-ciliopathyUNIV PENNSYLVANIA·Filed 2019·Application pending·0 cites
- 2161US12377169B2Dual AAV-MYO7A vectors with improved safety for the treatment of USH1BUNIV FLORIDA·Filed 2021·Granted Aug 5, 2025·0 cites·14 claims
- 2259US2024415983A1Aav-mediated therapies for vision loss associated with friedreich’s ataxiaUNIV FLORIDA·Filed 2022·Application pending·0 cites
- 2359US2023265455A1Improved aav-mediated x-linked retinoschisis therapiesUNIV FLORIDA·Filed 2021·Application pending·0 cites
- 2459US2023183741A1Disease correction by delivery of aav8 vectors expressing codon optimized nagluUNIV FLORIDA·Filed 2021·Application pending·0 cites
- 2555US12359221B2Compositions and methods for expressing otoferlinUNIV FLORIDA·Filed 2018·Granted Jul 15, 2025·0 cites·9 claims
- 2654US2017348387A1Aav-mediated gene therapy for nphp5 lca-ciliopathyUNIV PENNSYLVANIA·Filed 2017·Application pending·0 cites
- 2754US2018100165A1Raav-guanylate cyclase compositions and methods for treating leber's congenital amaurosis-1 (lca1)UNIV FLORIDA·Filed 2017·Application pending·0 cites
- 2850US2022133909A1Highly efficient transduction and lateral spread in the retina by a novel aav virus enhanced by rational designUNIV FLORIDA·Filed 2020·Application pending·0 cites
- 2940US2020330611A1Methodology for identifying gene delivery vectors with retinal cell specificity in non-human primateUNIV FLORIDA·Filed 2017·Application pending·0 cites
- 3037US2017007720A1Methods and compositions for gene delivery to on bipolar cellsUNIV FLORIDA·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →